Copy
Issue 24, September 2021
Updates from the Therapeutic Innovation Networks (TINs)
Are you an Early Career Researcher looking for a translational funding opportunity that will help you take your project forward? Or maybe you are a PI with postdoctoral researchers in your lab who are looking to generate preliminary data for a translational project?

If the above relates to you, then look no further, as the TIN Pilot Data Schemes are inviting applications from Early Career Researchers for projects with an aim to accelerate the transition from discovery science to the early stages of therapeutic development by providing responsive and flexible funding to support preliminary translational work.

UCL TINs Pilot Data Scheme – Call 2 (Cell & Gene Therapy, Devices & Diagnostics, Regenerative Medicine, Repurposing, Small Molecules)
Who can apply: Postdoctoral Researchers and non-tenured Principal Investigators.
Application deadline:
24th October 2021

For all opportunities, shortlisted applicants will be required to deliver a 2-minute pitch of their proposal followed by 10mins Q&A to a panel of academic and industrial members at a Dragon’s Den style event. The scheme offers £5-10k for a project duration of 6 months.

For more information about the scheme and to apply, please download and complete an application form from the TINs website (which also includes associated training opportunities).
Learn More and Apply
Pan-TIN Updates
Venture Insight - Seminar series for Translational Researchers at UCL

Next week, we are running the first in a 3-seminar series to help UCL researchers better understand the suitability of venture capital (VC) as a translational funding option.
Seminar 1 - "What an earth is going on in a VC's mind?"
  • Monday 4th October, 2-3.30pm

Understanding which source of funding is the most appropriate at the right point in time is crucial for accelerating innovation and maximising impact. Knowing how a venture capitalist thinks – not just in terms of what they think of your particular project, but also how they think about their whole portfolio – is important when interacting with them. When interacting with any funder, it’s critical to understand their risk/return profile, their timeframe and their incentive structure. We’ll look at each of these factors for funding in general but more specifically for VC support, examining how a venture investor manages their portfolio and makes decisions about any given project or spinout.

This seminar is an opportunity for you to learn about what motivates VCs and for you to ask lots of questions from UCL’s own in-house venture fund, the UCL Technology Fund. This will enable you to better understand VCs and their behaviour when you interact with them.

Learn More and Register
TIN-Specific Updates
Devices & Diagnostics 
CALL OPEN: Impact Fellowship 2021-22 scheme - UCL Healthcare Engineering

UCL Institute of Healthcare Engineering's year-long Impact Fellowship scheme is now accepting applications for its 2021-22 cohort. The Fellowship is open to all UCL researchers whose work is related to digital and medical technologies. Deadline: 6th October 2021

The Fellowship will build researchers skills and explore ideas such as how to measure impact, how to engage new voices, values of co-production, how to engage with policymakers, how to communicate their research to different audiences and how to work with community groups and patients. The Fellows will receieve personalised training and mentoring, and will also be supported to take part in structured activities and access funding to allow them to practice their new skills. 
Learn More and Apply
Repurposing 
Repurposing TIN Seminar: How partnership drives innovation (6th Oct, 2.30-4.30pm)
In the third seminar of the Repurposing TIN series (next week, Wednesday 6th October, 2.30-4.30pm), our speakers, from industry, biotech, charities and non-profit organisations, will explore how new collaborative models with multi-stakeholder partnerships are being employed to maximise synergy among different sectors and the impact that such models have had in certain fields of medicine (e.g. rare and paediatric disorders and oncology) where drug repurposing plays a prominent role.

We will also discuss what major opportunities and pitfalls to look out for in drug repurposing partnering.
View Full Agenda and Register
Small Molecules
Funding opportunity from UKRI - "Develop new approaches to small molecule medicine"

The MRC-AstraZeneca Centre for Lead Discovery (CLD) aims to support academic researchers in discovering potential starting points for small molecule medicinal drugs.

In this opportunity to research starting points for small molecule medicinal drugs, academic researchers will benefit from unprecedented access to over two million molecules in AstraZeneca’s compound library, as well as its state-of-the-art high-throughput screening (HTS) facilities. The full economic cost of your project, including work conducted at AstraZeneca, can be up to £250,000. MRC will fund 80% of the full economic cost.

Learn More and Apply
Other Translational Funding Opportunities
MRC Developmental Pathway Funding Scheme (DPFS) outline
  • Submission Deadline: 24th November 2021
The DPFS scheme is a key part of the MRC's Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies.

The scheme supports academically led projects whose goals are to improve prevention, diagnosis, prognosis, or treatment of significant health needs, or that focus on developing research tools that increase the efficiency of developing interventions.

The Translational Research Group within UCL TRO provide support for MRC DPFS applications. If you would like to apply, please contact Translational Research Group Head, Dr Pamela Tranter (
p.tranter@ucl.ac.uk). 
More Information
Sight Research UK Translational Research Award
  • Submission Deadline: 30th November 2021
This Translational Research Award supports research projects with a clearly defined pathway to achieving patient benefit. Its goal is to help to accelerate the translation of scientific findings to the early stages of development of new therapies, devices, and diagnostics. Sight Research UK welcome projects that have robust commercial potential, likely to attract large scale follow-on funding from other charitable, statutory or industry funders.
More Information
Translational Training
ACCELERATE Success: Grant Writing for Translational Research
  • Wednesday 6th October 2021, 11-1.30pm
In contrast to academic/fellowship grant applications, applying for translational research and innovation grants is all about pitching the end vision and convincing funders that you know what it takes to get there: What is the unmet clinical need? How will you meet this need? What are the project milestones and how much will it cost? For many, the first step to pitching this vision is a written application.

By the end of the workshop, participants will;

  • Recognise the important elements of a translational research/innovation grant application
  • Recognise how to identify the risks of the project and outline how they will be managed
  • Explain how to strategically apply for funding based on the maturity of one’s project and how to link this with one’s project milestones
  • Describe how to protect intellectual property when submitting a funding application
  • Recognise how to simplify your message for a specific funding call
  • Recognise how to improve the likelihood of success by ensuring your application is understood and makes a good impression
  • Identify where to find support at UCL.
Although this training opportunity is open to all UCL researchers, we strongly encourage TIN Pilot Data Scheme applications to attend in order to finesse your application for the best chances of success. 
Register Here
TINs website TINs website
TRO website TRO website
Our mailing address is:
UCL Translational Research Office,
Maple House, 1st Floor 1A,
149 Tottenham Court Road,
London, W1T 7JA

Copyright © 2021 UCL Translational Research Office, All rights reserved.
You are receiving this email because you previously registered your interest in one or more of our TINs.
Click here to unsubscribe.






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
UCL TRO · 7/F Maple House · 149 Tottenham Court Rd · London, Cmd W1T 7NF · United Kingdom

Email Marketing Powered by Mailchimp